Category: Pharmaceuticals
The Breakthrough Therapy Designation program is specifically designed to accelerate the development & review for medications designed for life-threatening conditions. The vaccine received the designation for facilitating the prevention …
Dewpoint Therapeutics, a biopharma company that translates the evolving area of biomolecular condensates into drug discovery, has recently announced its debut with USD 60 million in a series A …
The new drug has been found to be an effective analgesic without being addictive. Pfizer Inc., the leading American pharmaceutical corporation, and the global healthcare conglomerate, Eli Lilly & …
Advent would be making a strategic investment in BioDuro to consolidate its position as a leading drug discovery & development services provider. The financial terms related to the partnership …
BHVN received an approval letter from FDA to proceed its BHV-3241 clinical trial BHV-3241 is a novel MPO inhibitor developed for MSA treatment Biohaven has slated the Phase 3 …
TG Therapeutics Inc., a U.S. based health care firm, has recently announced that its umbralisib (TGR-1202) treatment has been granted the Breakthrough Therapy Designation by the U.S. Food and …
Vertex Pharmaceuticals (Europe) Ltd. has reportedly announced that the European Commission has approved of the label extension for ORKAMBI. A lumacaftor/ivacaftor, ORKAMBI has been deemed safe for the treatment …
Biopharmaceutical company Achilles Therapeutics recently announced that it has received an approval from U.K. authorities for a Clinical Trial Application (CTA) to perform a Phase I/II study with a …
Chinese pharmaceutical company Luye Pharma has reportedly entered into an agreement with AstraZeneca China, which grants the company exclusive rights to market Luye Pharma’s Xuezhikang Capsules in the nation. …
The approval of Onstryv marks the beginning of hope for an estimated 100,000 Canadians afflicted with Parkinson’s Disease. Valeo Pharma Inc., together with Zambon S.p.A, has declared the official …
